{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:40:18Z","timestamp":1790944818443,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["M10414030001-05N1403-00140"],"award-info":[{"award-number":["M10414030001-05N1403-00140"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.jconrel.2007.10.008","type":"journal-article","created":{"date-parts":[[2007,11,9]],"date-time":"2007-11-09T09:31:29Z","timestamp":1194600689000},"page":"68-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Improved intrapulmonary delivery of site-specific PEGylated salmon calcitonin: Optimization by PEG size selection"],"prefix":"10.1016","volume":"125","author":[{"given":"Yu Seok","family":"Youn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Jung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hee","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Young","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seulki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang Choon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2007.10.008_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0958-1669(00)00202-0","article-title":"Emerging protein delivery methods","volume":"12","author":"Cleland","year":"2001","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2007.10.008_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-409X(98)00075-1","article-title":"Oral insulin delivery","volume":"35","author":"Carino","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2007.10.008_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0169-409X(89)90018-5","article-title":"Penetration and enzymatic barriers to peptide and protein absorption","volume":"4","author":"Lee","year":"1990","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2007.10.008_bib4","first-page":"331","article-title":"Recent progress in protein and peptide delivery by noninvasive routes","volume":"8","author":"Wearley","year":"1991","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2007.10.008_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1513\/pats.200409-049TA","article-title":"The lungs as a portal of entry for systemic drug delivery","volume":"1","author":"Patton","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.jconrel.2007.10.008_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/rr58","article-title":"The lung as a route for systemic delivery of therapeutic proteins and peptides","volume":"2","author":"Agu","year":"2001","journal-title":"Respir. Res."},{"key":"10.1016\/j.jconrel.2007.10.008_bib7","volume":"107","author":"Adjei","year":"1997"},{"key":"10.1016\/j.jconrel.2007.10.008_bib8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1461-5347(98)00086-8","article-title":"Polyethylene glycol-conjugated pharmaceutical proteins","volume":"1","author":"Baion","year":"1998","journal-title":"Pharmaceut. Sci. Technol. Today"},{"key":"10.1016\/j.jconrel.2007.10.008_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2007.10.008_bib10","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2007.10.008_bib11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0169-409X(03)00108-X","article-title":"Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates","volume":"55","author":"Caliceti","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2007.10.008_bib12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/00003088-200140070-00005","article-title":"Pegylation: a novel process for modifying pharmacokinetics","volume":"40","author":"Harris","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2007.10.008_bib13","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1210\/jc.2004-2229","article-title":"Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes, an analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial","volume":"90","author":"Fineberg","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jconrel.2007.10.008_bib14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1023\/A:1018861616465","article-title":"Isolation, characterization, and stability of positional isomers of mono-PEGylated salmon calcitonins","volume":"16","author":"Lee","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2007.10.008_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1081\/PDT-100101361","article-title":"Preparation and characterization of polyethylene glycol modified salmon calcitonins","volume":"4","author":"Lee","year":"1999","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2007.10.008_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/jps.10537","article-title":"Stability of PEGylated salmon calcitonin in nasal mucosa","volume":"93","author":"Na","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2007.10.008_bib17","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1248\/cpb.48.1921","article-title":"Pharmacokinetic disposition of polyethylene glycol-modified salmon calcitonin","volume":"48","author":"Yoo","year":"2000","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2007.10.008_bib18","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1248\/cpb.52.957","article-title":"Nasal absorption and pharmacokinetic disposition of salmon calcitonin, modified with low molecular weight polyethylene glycol","volume":"52","author":"Shin","year":"2004","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2007.10.008_bib19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jconrel.2006.06.007","article-title":"Improved intestinal delivery of salmon calcitonin by Lys18-amine specific PEGylation: stability, permeability, pharmacokinetic behavior and in vivo hypocalcemic efficacy","volume":"114","author":"Youn","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2007.10.008_bib20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1081\/PDT-65686","article-title":"Oral delivery of mono-PEGylated sCT (Lys18) in rats: regional difference in stability and hypocalcemic effect","volume":"10","author":"Mansoor","year":"2005","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2007.10.008_bib21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00223-002-0034-9","article-title":"Intranasal delivery of PEGylated salmon calcitonins: hypocalcemic effects in rats","volume":"73","author":"Lee","year":"2003","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.jconrel.2007.10.008_bib22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jconrel.2006.11.013","article-title":"High-yield production of biologically active mono-PEGylated salmon calcitonin by site-specific PEGylation","volume":"117","author":"Youn","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2007.10.008_bib23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1021\/bc060173z","article-title":"Site-specific PEGylation for high-yield preparation of Lys(21)-amine PEGylated growth hormone-releasing factor (GRF) (1\u201329) using a GRF(1\u201329) derivative FMOC-protected at Tyr(1) and Lys(12)","volume":"18","author":"Youn","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2007.10.008_bib24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0304-4165(01)00125-8","article-title":"Discovery of a non-peptide small molecule that selectively mimics the biological actions of calcitonin","volume":"1526","author":"Katayama","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2007.10.008_bib25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1152\/ajplegacy.1972.222.2.409","article-title":"Absorption of saccharides and urea from the rat lung","volume":"222","author":"Enna","year":"1972","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jconrel.2007.10.008_bib26","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1023\/A:1018926007902","article-title":"Study on pulmonary delivery of salmon calcitonin in rats: effects of protease inhibitors and absorption enhancer","volume":"11","author":"Kobayashi","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2007.10.008_bib27","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1023\/A:1018950429341","article-title":"Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various protease inhibitors in rats","volume":"11","author":"Morita","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2007.10.008_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1023\/A:1016081301369","article-title":"Pulmonary delivery of salmon calcitonin dry powders containing absorption enhancers in rats","volume":"13","author":"Kobayashi","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2007.10.008_bib29","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1023\/A:1016281925554","article-title":"The pulmonary absorption of aerosolized and intratracheally instilled rhG-CSF and monoPEGylated rhG-CSF","volume":"12","author":"Niven","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2007.10.008_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0378-5173(81)90009-0","article-title":"Effect of surfactants to nasal absorption of insulin in rats","volume":"9","author":"Hirai","year":"1981","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2007.10.008_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0168-3659(94)90155-4","article-title":"Bioavailability of pulmonary delivery of peptides and proteins: alpha-interferon, calcitonins, and parathyroid hormones","volume":"28","author":"Patton","year":"1994","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2007.10.008_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0169-409X(95)00113-L","article-title":"Mechanisms of macromolecular absorption by the lungs","volume":"19","author":"Patton","year":"1996","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2007.10.008_bib33","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0169-409X(03)00109-1","article-title":"PEGylation of growth hormone-releasing hormone (GRF) analogues","volume":"55","author":"Esposito","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2007.10.008_bib34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bcp.2006.09.013","article-title":"Evaluation of therapeutic potentials of site-specific PEGylated glucagon-like peptide-1 isomers as a type 2 anti-diabetic treatment: insulinotropic activity, glucose-stabilizing capability, and proteolytic stability","volume":"73","author":"Youn","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2007.10.008_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1046-5928(03)00055-X","article-title":"Isolation, structural characterization, and antiviral activity of positional isomers of monopegylated interferon alpha-2a (PEGASYS)","volume":"30","author":"Foser","year":"2003","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jconrel.2007.10.008_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2003.10.001","article-title":"Absorption enhancers in pulmonary protein delivery","volume":"94","author":"Hussain","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2007.10.008_bib37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s002239900345","article-title":"Intrapulmonary drug delivery of salmon calcitonin","volume":"61","author":"Deftos","year":"1997","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.jconrel.2007.10.008_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/1061186042000223644","article-title":"Pulmonary absorption enhancement of salmon calcitonin","volume":"12","author":"Kumar","year":"2004","journal-title":"J. Drug Target."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365907005627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365907005627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:21:26Z","timestamp":1759159286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365907005627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0168365907005627"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2007.10.008","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved intrapulmonary delivery of site-specific PEGylated salmon calcitonin: Optimization by PEG size selection","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2007.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}